Please wait while the formulary information is being retrieved.
TYRVAYA (varenicline tartrate)
- severe decrease in normal tears
0.03 mg/spray nasal spray
- Spray 1 spray (0.03 mg) in each nostril by intranasal route 2 times per day approximately 12 hours apart
Default screening record
- Spray 1 spray (0.03 mg) in each nostril by intranasal route 2 times per day approximately 12 hours apart
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- No disease contraindications
TYRVAYA (varenicline tartrate)
- severe decrease in normal tears
- None
- Sneezing
More Frequent
Severe
Less Severe
- None
- Cough
- Nasal passage irritation
- Pharyngitis
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- None
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Varenicline (nasal)
Safety and effectiveness not established in pediatric patients < 18 years.
- 1 Day – 18 Years
- Safety and effectiveness not established in pediatric patients < 18 years.
Varenicline
- Severity Level:
2
- Additional Notes: Insufficient human data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Varenicline
Insufficient human data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient human data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Tear film insufficiency | |
| H04.12 | Dry eye syndrome |
| H04.121 | Dry eye syndrome of right lacrimal gland |
| H04.122 | Dry eye syndrome of left lacrimal gland |
| H04.123 | Dry eye syndrome of bilateral lacrimal glands |
| H04.129 | Dry eye syndrome of unspecified lacrimal gland |
| 0-9 | A-Z |
|---|---|
| H04.12 | Dry eye syndrome |
| H04.121 | Dry eye syndrome of right lacrimal gland |
| H04.122 | Dry eye syndrome of left lacrimal gland |
| H04.123 | Dry eye syndrome of bilateral lacrimal glands |
| H04.129 | Dry eye syndrome of unspecified lacrimal gland |
Formulary Reference Tool